I have read about CV from SA saying in previous news releases that SA would rather buy into emerging companies and fund them let their management team and inventors run the company, as the people who invent and start the emerging companies are often the best to run the company rather than a global pharma try and take over someone else’s baby.
I think that’s why they are funding us to the hilt, a takeover could be on the cards..
I like both scenarios
UNI Price at posting:
26.0¢ Sentiment: ST Buy Disclosure: Held
